This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Banerjee, C. Articles by Stein, G. S. Search for Related Content PubMed PubMed Citation Articles by Banerjee, C. Articles by Stein, G. S.

Differential Regulation of the Two Principal Runx2/Cbfa1 N-Terminal Isoforms in Response to Bone Morphogenetic Protein-2 during Development of the Osteoblast Phenotype

Department of Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01655; and Genetics Institute (V.R.), Cambridge, Massachusetts 02140

Address all correspondence and requests for reprints to: Dr. Jane B. Lian, Department of Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01655. E-mail: jane.lian{at}umassmed.edu

Cbfa1/Runx2 is a transcription factor essential for bone formation and osteoblast differentiation. Two major N-terminal isoforms of Cbfa1, designated type I/p56 (PEBP2aA1, starting with the sequence MRIPV) and type II/p57 (til-1, starting with the sequence MASNS), each regulated by distinct promoters, are known. Here, we show that the type I transcript is constitutively expressed in nonosseous mesenchymal tissues and in osteoblast progenitor cells. Cbfa1 type I isoform expression does not change with the differentiation status of the cells. In contrast, the type II transcript is increased during differentiation of primary osteoblasts and is induced in osteoprogenitors and in premyoblast C2C12 cells in response to bone morphogenetic protein-2. The functional equivalence of the two isoforms in activation and repression of bone-specific genes indicates overlapping functional roles. The presence of the ubiquitous type I isoform in nonosseous cells and before bone morphogenetic protein-2 induced expression of the type II isoform suggests a regulatory role for Cbfa1 type I in early stages of mesenchymal cell development, whereas type II is necessary for osteogenesis and maintenance of the osteoblast phenotype. Our data indicate that Cbfa1 function is regulated by transcription, cellular protein levels, and DNA binding activity during osteoblast differentiation. Taken together, our studies suggest that developmental timing and cell type- specific expression of type I and type II Cbfa isoforms, and not necessarily molecular properties or sequences that reside in the N-terminus of Cbfa1, are the principal determinants of the osteogenic activity of Cbfa1.

This article has been cited by other articles:

				S.-L. Cheng, J.-S. Shao, J. Cai, O. L. Sierra, and D. A. Towler Msx2 Exerts Bone Anabolism via Canonical Wnt Signaling J. Biol. Chem., July 18, 2008; 283(29): 20505 - 20522. [Abstract] [Full Text] [PDF]

				S. Chen, J. Gluhak-Heinrich, M. Martinez, T. Li, Y. Wu, H.-H. Chuang, L. Chen, J. Dong, I. Gay, and M. MacDougall Bone Morphogenetic Protein 2 Mediates Dentin Sialophosphoprotein Expression and Odontoblast Differentiation via NF-Y Signaling J. Biol. Chem., July 11, 2008; 283(28): 19359 - 19370. [Abstract] [Full Text] [PDF]

				V. Lamour, C. Detry, C. Sanchez, Y. Henrotin, V. Castronovo, and A. Bellahcene Runx2- and Histone Deacetylase 3-mediated Repression Is Relieved in Differentiating Human Osteoblast Cells to Allow High Bone Sialoprotein Expression J. Biol. Chem., December 14, 2007; 282(50): 36240 - 36249. [Abstract] [Full Text] [PDF]

				A. Simionescu, D. T. Simionescu, and N. R. Vyavahare Osteogenic Responses in Fibroblasts Activated by Elastin Degradation Products and Transforming Growth Factor-{beta}1: Role of Myofibroblasts in Vascular Calcification Am. J. Pathol., July 1, 2007; 171(1): 116 - 123. [Abstract] [Full Text] [PDF]

				M. Q. Hassan, R. S. Tare, S. H. Lee, M. Mandeville, M. I. Morasso, A. Javed, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian BMP2 Commitment to the Osteogenic Lineage Involves Activation of Runx2 by DLX3 and a Homeodomain Transcriptional Network J. Biol. Chem., December 29, 2006; 281(52): 40515 - 40526. [Abstract] [Full Text] [PDF]

				A. E. Handschin, M. Egermann, O. Trentz, G. A. Wanner, H.-J. Kock, G. Zund, and O. A. Trentz Cbfa-1 (Runx-2) and Osteocalcin Expression by Human Osteoblasts in Heparin Osteoporosis in Vitro Clinical and Applied Thrombosis/Hemostasis, October 1, 2006; 12(4): 465 - 472. [Abstract] [PDF]

				J. E. Phillips, C. A. Gersbach, A. M. Wojtowicz, and A. J. Garcia Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation J. Cell Sci., February 1, 2006; 119(3): 581 - 591. [Abstract] [Full Text] [PDF]

				H. Seeherman, R. Li, M. Bouxsein, H. Kim, X. J. Li, E. A. Smith-Adaline, M. Aiolova, and J. M. Wozney rhBMP-2/Calcium Phosphate Matrix Accelerates Osteotomy-Site Healing in a Nonhuman Primate Model at Multiple Treatment Times and Concentrations J. Bone Joint Surg. Am., January 1, 2006; 88(1): 144 - 160. [Abstract] [Full Text] [PDF]

				M.-H. Lee, Y.-J. Kim, W.-J. Yoon, J.-I. Kim, B.-G. Kim, Y.-S. Hwang, J. M. Wozney, X.-Z. Chi, S.-C. Bae, K.-Y. Choi, et al. Dlx5 Specifically Regulates Runx2 Type II Expression by Binding to Homeodomain-response Elements in the Runx2 Distal Promoter J. Biol. Chem., October 21, 2005; 280(42): 35579 - 35587. [Abstract] [Full Text] [PDF]

				S. Chen, S. Rani, Y. Wu, A. Unterbrink, T. T. Gu, J. Gluhak-Heinrich, H.-H. Chuang, and M. MacDougall Differential Regulation of Dentin Sialophosphoprotein Expression by Runx2 during Odontoblast Cytodifferentiation J. Biol. Chem., August 19, 2005; 280(33): 29717 - 29727. [Abstract] [Full Text] [PDF]

				M. Galindo, J. Pratap, D. W. Young, H. Hovhannisyan, H.-J. Im, J.-Y. Choi, J. B. Lian, J. L. Stein, G. S. Stein, and A. J. van Wijnen The Bone-specific Expression of Runx2 Oscillates during the Cell Cycle to Support a G1-related Antiproliferative Function in Osteoblasts J. Biol. Chem., May 27, 2005; 280(21): 20274 - 20285. [Abstract] [Full Text] [PDF]

				H. Kojima and T. Uemura Strong and Rapid Induction of Osteoblast Differentiation by Cbfa1/Til-1 Overexpression for Bone Regeneration J. Biol. Chem., January 28, 2005; 280(4): 2944 - 2953. [Abstract] [Full Text] [PDF]

				N. Selvamurugan, S. Kwok, and N. C. Partridge Smad3 Interacts with JunB and Cbfa1/Runx2 for Transforming Growth Factor-{beta}1-stimulated Collagenase-3 Expression in Human Breast Cancer Cells J. Biol. Chem., June 25, 2004; 279(26): 27764 - 27773. [Abstract] [Full Text] [PDF]

				Z.-S. Xiao, A. B. Hjelmeland, and L. D. Quarles Selective Deficiency of the "Bone-related" Runx2-II Unexpectedly Preserves Osteoblast-mediated Skeletogenesis J. Biol. Chem., May 7, 2004; 279(19): 20307 - 20313. [Abstract] [Full Text] [PDF]

				M. Komaki, A. Asakura, M. A. Rudnicki, J. Sodek, and S. Cheifetz MyoD enhances BMP7-induced osteogenic differentiation of myogenic cell cultures J. Cell Sci., March 15, 2004; 117(8): 1457 - 1468. [Abstract] [Full Text] [PDF]

				J. Pratap, M. Galindo, S. K. Zaidi, D. Vradii, B. M. Bhat, J. A. Robinson, J.-Y. Choi, T. Komori, J. L. Stein, J. B. Lian, et al. Cell Growth Regulatory Role of Runx2 during Proliferative Expansion of Preosteoblasts Cancer Res., September 1, 2003; 63(17): 5357 - 5362. [Abstract] [Full Text] [PDF]

				E. Canalis, A. N. Economides, and E. Gazzerro Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton Endocr. Rev., April 1, 2003; 24(2): 218 - 235. [Abstract] [Full Text] [PDF]

				D. M. Willis, A. P. Loewy, N. Charlton-Kachigian, J.-S. Shao, D. M. Ornitz, and D. A. Towler Regulation of Osteocalcin Gene Expression by a Novel Ku Antigen Transcription Factor Complex J. Biol. Chem., September 27, 2002; 277(40): 37280 - 37291. [Abstract] [Full Text] [PDF]

				M. J. Silva and L. J. Sandell What's New in Orthopaedic Research J. Bone Joint Surg. Am., August 12, 2002; 84(8): 1490 - 1496. [Full Text] [PDF]

				M. Stewart, N. MacKay, E. R. Cameron, and J. C. Neil The Common Retroviral Insertion Locus Dsi1 Maps 30 Kilobases Upstream of the P1 Promoter of the Murine Runx3/Cbfa3/Aml2 Gene J. Virol., March 27, 2002; 76(9): 4364 - 4369. [Abstract] [Full Text] [PDF]

				L. Gilbert, X. He, P. Farmer, J. Rubin, H. Drissi, A. J. van Wijnen, J. B. Lian, G. S. Stein, and M. S. Nanes Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) Is Inhibited by Tumor Necrosis Factor-alpha J. Biol. Chem., January 18, 2002; 277(4): 2695 - 2701. [Abstract] [Full Text] [PDF]